there is a high degree of inter-and intra-familial phenotypic variability. As such it is not uncommon for severely affected patients to be registered blind from a young age, whereas mildly affected individuals can be completely asymptomatic. In their study, Shastry and Trese speculated that this variable phenotype may be due to oligogenic inheritance, with specific alleles at multiple loci affecting the severity and range of features seen in a patient. In particular, they hypothesised that factor V Leiden may be one of these modifying alleles and undertook a study to assess if it had any role in the pathogenesis of FEVR. 1 Shastry and Trese screened for the presence of factor V Leiden in 14 unrelated FEVR families and identified it in only one. Coincidentally, this was the only family out of the 14 screened with a known mutation (c1501 -1502delCT) within the frizzled-4 gene (FZD4), 2 mutations in which are known to account for approximately 20 -40% of FEVR cases. 2, 7, 8 Both mutations were present in all five affected members of this family but were not in three unaffected individuals, indicating that the two unlinked mutant alleles were cosegregating. Furthermore, all these mutation carrying individuals had suffered retinal detachments at an early age, suggesting that their phenotype was particularly severe. Unfortunately, the authors were not able to determine the contribution each gene made to the FEVR phenotype because all affected individuals inherited both mutations and they did not have any additional individuals with inherited mutations in only one of these genes. However, in their paper Shastry and Trese 9,10 failed to mention the widely reported observation that approximately 5% of the population are carriers of the factor V Leiden allele. In fact, the authors give the impression that this is not the case by reporting its exclusion in 40 control individuals. 1 The family detailed in their report was of European descent 2 and population studies have shown that factor V Leiden has highest frequency in this ethnic background, with figures suggesting that between 3 and 10% of Europeans are heterozygous carriers of the allele. 9,11 -13 Shastry and Trese identified the factor V Leiden allele in one of the 14 families they examined, giving a frequency of 7% (1/14) which is consistent with published figures. Furthermore, the fact that factor V Leiden segregates with the disease in their pedigree is not statistically significant as the family is small. Two-point linkage analysis of factor V Leiden with FEVR produces a maximum LOD score of only 1.49 at theta ¼ 0 well below 3, the required level of significance. We therefore questioned whether the reported association of FZD4 and Leiden mutations in a single small FEVR family could be purely due to chance.
To answer this question, we screened 14 unrelated families with various forms of FEVR for the presence of factor V Leiden. We used the same method as Shastry and Trese, which identifies the mutation by the loss of an MnlI cleavage site, and confirmed detection of the allele in a panel of controls before initiating the study. Ethical approval was obtained from the Leeds Teaching Hospitals Trust Research Ethics Committee. In eight families with known mutations in FZD4, 8 our analysis showed that none of the 64 individuals tested, 33 of whom carried FZD4 mutations, contained the Leiden allele. Included in this group were six affected members of a North American family segregating the same two-bp deletion in FZD4 as that found in the family reported by Shastry and Trese, including some with retinal detachment. 8 The lack of a factor V Leiden allele in this family indicates that this two-bp deletion in FZD4 alone is sufficient to cause FEVR, ruling out the possibility that the reported effect of the factor V Leiden allele was specific for this mutation. The other FEVR families screened for the Leiden mutation include one family from the EVR3 locus, 4 three families from the EVR4 locus, 5,14 a further autosomal dominant family in whom linkage to the known loci had been
www.nature.com/ejhg excluded 6 and a recessive family in whom no linkage analysis had been undertaken. 15 We agree with Shastry and Trese in that the variable phenotype observed in FEVR patients could well be due to modifying genes at other loci as well as environmental effects. However, to prove such a link, evidence must be presented showing that individuals containing two mutant alleles consistently have a different phenotype (either more severe or milder) than those with only one. The results presented by Shastry and Trese are interesting but anecdotal, since they provide no statistically significant evidence that factor V Leiden has an effect on the FEVR phenotype. We understand that the authors have very carefully worded their discussion so that they do not actually come to any conclusions about their finding and only suggest possibilities, but the fact that this cosegregation could be simply due to chance is not discussed. Indeed, the authors state that 'the cosegregation of unlinked genes in such a small family is statistically unlikely'. As we have shown, this statement is not supported by the data these authors presented. Furthermore, the lack of Leiden mutations in our FEVR patient cohort suggests that the factor V Leiden does not play a significant role in FEVR severity and that further studies are needed to dissect out the complexities of the variable phenotypes observed in FEVR patients. 
